TRPV2 and neoplasm: Therapeutic strategies encompass enhanced calcium influx to activate signaling pathways or calcium‐based nanomaterials for cellular calcium overload, triggering tumor calcification and immune responses through pyroptosis.[4, 5] However, conventional TRPV2 activators (e.g., 2‐APB, probenecid, CBD) face low specificity and potential side effects.[11, 16] Thus, identifying a specific and effective method to activate TRPV2 remains challenging and a substantial research focus.